Health
Body’s immune response drives production of non-functional COVID ‘gateway protein’: Study – Times of India
In the study, scientists, including those from the Francis Crick Institute in London, analysed existing genetic dat
Some immune system molecules trigger the production of a non-functional variant of the human protein used by the novel coronavirus to enter and infect host cells, according to a study that sheds light on the body’s natural defence against COVID-19. The research, published in the journal Nature Genetics, examined the genetic information that codes for the ACE2 receptor, to which the SARS-CoV-2 virus must bind in order to enter and infect human cells.
In the study, scientists, including those from…
-
Business18 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News18 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business14 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News16 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses